Resources
8 Results (showing 1 - 8)
Results sorted by posted date (oldest first)
Results sorted by posted date (oldest first)
Posted 3/19/2020 (updated 3/28/2024)
To help local leaders respond to this epidemic, USDA has worked to build infrastructure for prevention, treatment and recovery, facilitate partnerships, and drive innovation in rural communities.
Posted 2/3/2021 (updated 4/4/2024)
The opioid epidemic is the result of a complex system of varied and interrelated factors. This webinar introduced a systems thinking approach and tools to address such complex public health challenges. The Georgia Health Policy Center’s Opioid Systems Map was presented as a case study for the creation and application of systems mapping in local communities. The webinar fostered a holistic view of the opioid epidemic and described opportunities to further develop systems thinking capacity for application to grantees’ local opioid response.
Posted 3/2/2021 (updated 4/4/2024)
In light of the accelerating and rapidly evolving overdose crisis in the United States (US), new strategies are needed to address the epidemic and to efficiently engage and retain individuals in care for opioid use disorder (OUD). Moreover, there is an increasing need for novel approaches to using health data to identify gaps in the cascade of care for persons with OUD.
Posted 8/4/2021 (updated 4/2/2024)
Posted 3/16/2022 (updated 3/27/2024)
Background: Sharp exacerbations of the US overdose crisis are linked to polysubstance use of synthetic compounds. Xylazine is a veterinary tranquilizer, long noted in the street opioid supply of Puerto Rico, and more recently Philadelphia. Yet its national trends, geographic distribution, and health risks are poorly characterized. Methods: In this sequential mixed-methods study, xylazine was increasingly observed by ethnographers in Philadelphia among drug-sellers and people who inject drugs (PWID). Subsequently, we systematically searched for records describing xylazine-present overdose mortality across the US and assessed time trends and overlap with other drugs
Posted 3/22/2022 (updated 3/27/2024)
The purpose of this document is to provide detailed guidelines of the Nurse Care Manager Model of Office Based Addiction Treatment program for management of substance use disorders, with particular emphasis on treatment of opioid use disorder with buprenorphine (alone and in combination with naloxone) and naltrexone (oral and extended-release injectable formulations).
Posted 9/28/2022 (updated 3/27/2024)
Last week, the U.S. Department of Health & Human Services (HHS) introduced the Roadmap for Behavioral Health Integration, to advance the White House Strategy to Address our National Mental Health Crisis announced earlier this year.
Posted 12/1/2023 (updated 3/28/2024)
This publication highlights the Coordinated Opioid Recovery (CORE) Program in three Florida counties. The program integrates a new facet of Emergency Medical Services known as community paramedics. Since its launch in 2022 in Palm Beach County, Florida, CORE has expanded to include 12 additional Florida counties and takes a coordinated approach to recovery for individuals with SUD.